Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use

The clinical exploitation of type I interferon (IFN) as an antiviral and antineoplastic agent is based on the properties originally attributed to this cytokine family, with schedules reflecting only their antiviral and antiproliferative activities. Nevertheless, type I IFN has emerged as a central a...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonelli, Guido, Scagnolari, Carolina, Moschella, Federica, Proietti, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108252/
https://www.ncbi.nlm.nih.gov/pubmed/25578520
http://dx.doi.org/10.1016/j.cytogfr.2014.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108252/
https://www.ncbi.nlm.nih.gov/pubmed/25578520
http://dx.doi.org/10.1016/j.cytogfr.2014.12.006

Ejemplares similares